• Bora Corporate

Contact Us

Bora Pharmaceutical CDMO
  • Dosage Forms
    • Oral Solid Dose
    • Semi-Solids
    • Liquids
    • Nasal Sprays
    • Ophthalmic
  • Manufacturing &
    Packaging
    • Small Scale and Pilot
    • Scale-Up and Commercial
    • Packaging & Serialization
  • Development &
    Analytical Services
    • Formulation Development
    • Analytical Development
    • Analytical Testing
    • Stability Testing and Storage
  • Biologics
    • Cell Line & Process Development
    • Analytical & Formulation Development
    • Manufacturing
  • Technologies
    • Handling Solvents
    • Modified Release
    • Extrusion Spheronization
    • Wurster Coating
  • Company News
    • Resources
  • About
    • Leadership Team
    • Why Choose Bora
      • Quality
      • Culture
      • Sustainability
    • Locations
      • North America
      • Asia
        • Tainan
        • Zhunan
        • Zhongli
        • Taoyuan
        • Zhubei
    • Careers
    • Contact Us
Bora Pharmaceuticals Featured in Contract Pharma – What are 3 Key Trends shaping the CDMO industry in 2023 and beyond?

Bora Pharmaceuticals Featured in Contract Pharma – What are 3 Key Trends shaping the CDMO industry in 2023 and beyond?

by Brinette Holdren | Jun 22, 2023 | News and Events, Press Mentions

Read Contract Pharma – “What are 3 Key Trends shaping the CDMO industry in 2023 and beyond?” Published on June 22, 2023 Bobby Sheng sheds some light on the three main trends impacting CDMOs in 2023 – and potentially for many years ahead. One...
Bora Pharmaceuticals Featured in Pharma Manufacturing – Three Fast Growing CDMOs to Watch

Bora Pharmaceuticals Featured in Pharma Manufacturing – Three Fast Growing CDMOs to Watch

by shannon | Feb 7, 2023 | News and Events, Press Mentions

Read Pharma Manufacturing’s feature article entitled “Built to Thrive: Three CDMOs that set themselves up to flourish” Published on February 7, 2023 Thank you Pharma Manufacturing and author Karen Longhauser Pharma Manufacturing’s feature...
Bora Pharmaceuticals Featured in Contract Pharma – What are 3 Key Trends shaping the CDMO industry in 2023 and beyond?

Bora Pharmaceuticals Featured in Fierce Pharma – Bora’s Quest to Join Ranks of Top CDMOs

by shannon | Nov 10, 2022 | News and Events, Press Mentions

Fierce Pharma features a discussion with CEO, Bobby Sheng in an article entitled “After Bora’s biologics debut, CEO outlines quest to join ranks of top CDMOs”. Published on November 10, 2022Thank you Fierce Pharma and author Fraiser Kansteiner...
Why it can take so long to validate pharmaceutical manufacturing processes during site-to-site technology transfers and what can be done to speed it up

Why it can take so long to validate pharmaceutical manufacturing processes during site-to-site technology transfers and what can be done to speed it up

by shannon | Sep 26, 2022 | Articles

Process validation too slow? Here’s how to speed things up Technology transfers and process validation are an integral part of drug development and commercial drug product manufacturing. Successful technology transfer from site-to-site requires careful evaluation of...
Supply chain disruptions and their impact on quality and operations

Supply chain disruptions and their impact on quality and operations

by shannon | Aug 2, 2022 | Articles

COVID-19’s impact on global supply chains as well as tectonic geopolitical shifts have resulted in considerable disruption, particularly to the contract development and manufacturing organization (CDMO) industry. Looking back, what is troubling about the supply chain...
« Older Entries

Recent Posts

  • Strategies and tactics for success in biologics analytical testing
  • eBook – Addressing the complex demands of cell line development
  • Customized solutions for biologics development: leveraging adaptive platforms to meet customer needs
  • 22nd Annual Contracting & Outsourcing Conference
  • Bio Japan 2023
Bora Pharmaceutical CDMO

In the world of pharmaceutical outsourcing, success is far from certain, and failure costs a lot. At Bora Pharmaceuticals, we see it as our mission and our duty to make our mutual success more certain. As an ambitious, future-focused CDMO, we know better than most that our own success is shaped by our partners victories.

See how we do it
  • FollowFollow
  • About
  • Locations
  • Company News
  • Resources
  • Sustainability
  • Quality
  • Dosage Forms
  • Manufacturing & Packaging
  • Development & Analytical Services
  • Technologies
Stay Connected

Get the industry insights you care about. Join 3000+ subscribers and receive Bora resources and updates by email. 

  • Technology Transfer
  • Technology Transfer
Copyright © 2023 Bora Pharmaceutical CDMO
  • Bora Corporate
  • Sitemap
  • Privacy Policy